X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anti-bacterial agents - pharmacology (27) 27
chemistry, medicinal (22) 22
structure-activity relationship (21) 21
humans (20) 20
microbial sensitivity tests (20) 20
anti-bacterial agents - chemical synthesis (19) 19
anti-bacterial agents - chemistry (19) 19
animals (16) 16
pharmacology & pharmacy (16) 16
chemistry, organic (14) 14
microbiology (14) 14
erythromycin - pharmacology (11) 11
female (10) 10
haemophilus influenzae - drug effects (9) 9
streptococcus pneumoniae - drug effects (9) 9
adult (8) 8
erythromycin - analogs & derivatives (8) 8
rats (8) 8
resistance (8) 8
staphylococcus aureus - drug effects (8) 8
derivatives (7) 7
drug resistance, bacterial (7) 7
infectious diseases (7) 7
ketolides (7) 7
mice (7) 7
antibiotics (6) 6
bacteria - drug effects (6) 6
biotechnology & applied microbiology (6) 6
drug resistance, microbial (6) 6
erythromycin - chemical synthesis (6) 6
erythromycin - chemistry (6) 6
gram-positive bacteria - drug effects (6) 6
immunology (6) 6
male (6) 6
streptococcus-pneumoniae (6) 6
antibacterial activity (5) 5
gram-negative bacteria - drug effects (5) 5
hiv infections - drug therapy (5) 5
in-vitro (5) 5
macrolides (5) 5
middle aged (5) 5
therapy (5) 5
antibacterial agents (4) 4
drug resistance, multiple (4) 4
index medicus (4) 4
invitro (4) 4
macrolides - pharmacology (4) 4
microbial sensitivity tests - methods (4) 4
molecular structure (4) 4
respiratory tract infections - microbiology (4) 4
staphylococcus - drug effects (4) 4
streptococcus pneumoniae - genetics (4) 4
streptococcus pyogenes - drug effects (4) 4
treatment outcome (4) 4
agents (3) 3
anti-bacterial agents - pharmacokinetics (3) 3
antibiotic-resistance (3) 3
antifungal agents - chemistry (3) 3
antifungal agents - pharmacology (3) 3
antimicrobial resistance (3) 3
antiviral agents (3) 3
azithromycin (3) 3
bacteria (3) 3
bacterial infections and mycoses (3) 3
biological availability (3) 3
cefdinir (3) 3
clarithromycin - pharmacology (3) 3
dna gyrase - genetics (3) 3
drug administration schedule (3) 3
drug design (3) 3
drug resistance in microorganisms (3) 3
drug therapy, combination (3) 3
erythromycin (3) 3
erythromycin-a (3) 3
gyrase (3) 3
haemophilus-influenzae (3) 3
half-life (3) 3
hiv-1 - drug effects (3) 3
ketolide (3) 3
lopinavir (3) 3
macrolide resistance (3) 3
mechanisms (3) 3
models, molecular (3) 3
naphthyridines - pharmacology (3) 3
protein biosynthesis (3) 3
protein-synthesis (3) 3
ribosomes - drug effects (3) 3
tenofovir (3) 3
transcription, genetic (3) 3
united-states (3) 3
viral load (3) 3
virology (3) 3
abt-719 (2) 2
abt-773 (2) 2
acute disease (2) 2
algorithms (2) 2
anti-bacterial agents - metabolism (2) 2
anti-bacterial agents - therapeutic use (2) 2
anti-hiv agents - adverse effects (2) 2
anti-infective agents - pharmacology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


HIV Clinical Trials, ISSN 1528-4336, 10/2011, Volume 12, Issue 5, pp. 255 - 267
Purpose: Current antiretroviral regimens recommended for treatment-naïve patients include 2 nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs). The... 
HIV-1 | raltegravir | emtricitabine | NRTI-sparing | lopinavir | tenofovir | INFECTIOUS DISEASES | EFFICACY | COMBINATION THERAPY | REGIMEN | TRIAL | PHARMACOLOGY & PHARMACY | HIV-1 INFECTION | United States | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | Viral Load | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Ritonavir - adverse effects | Adenine - therapeutic use | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Antiretroviral Therapy, Highly Active - methods | Drug Therapy, Combination | Raltegravir Potassium | United States Food and Drug Administration | Emtricitabine | HIV Protease Inhibitors - adverse effects | Pyrrolidinones - adverse effects | Adenine - analogs & derivatives | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Organophosphonates - adverse effects | Pyrrolidinones - therapeutic use | Treatment Outcome | HIV-1 - genetics | HIV Protease Inhibitors - therapeutic use | Algorithms | HIV Integrase Inhibitors - adverse effects | HIV Integrase Inhibitors - therapeutic use | HIV Infections - drug therapy | Lopinavir - therapeutic use | Deoxycytidine - analogs & derivatives | Lopinavir - adverse effects
Journal Article
Antimicrobial Agents & Chemotherapy, ISSN 0066-4804, 09/2007, Volume 51, Issue 9, pp. 3381 - 3384
A clinical trial of uncomplicated skin and skin structure infections (39 locations in 19 states) observed that community-associated or community-onset... 
Journal Article
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2015, Volume 20, Issue 4, pp. 425 - 432
Background: A novel ritonavir oral powder formulation has been developed to eliminate the alcohol and propylene glycol contents in the current ritonavir oral... 
INFECTIOUS DISEASES | PHARMACOLOGY & PHARMACY | MECHANISMS | VIROLOGY
Journal Article
Journal Article
Shock, ISSN 1073-2322, 06/2002, Volume 17, Issue 6, pp. 530 - 531
Journal Article
Bioorganic and Medicinal Chemistry Letters, ISSN 0960-894X, 04/2000, Volume 10, Issue 8, pp. 815 - 819
A series of novel 6-O-substituted erythromycin A derivatives has been synthesized. Good in vitro antibacterial activity has been demonstrated for analogues... 
Journal Article
Bioorganic & medicinal chemistry letters, ISSN 0960-894X, 07/2004, Volume 14, Issue 14, p. 3809
Journal Article
Bioorganic & medicinal chemistry letters, ISSN 0960-894X, 05/2004, Volume 14, Issue 10, pp. 2417 - 2421
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2001, Volume 44, Issue 24, pp. 4137 - 4156
Journal Article
The Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 05/2002, Volume 49, Issue 5, p. 831
  Attempts were made to select mutants on agar media containing the new ketolide ABT-773, erythromycin or rifampicin, at concentrations above the MICs, from... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.